Praxis Precision Medicines Newsroom

Express News | Praxis Precision Medicines : Sales Agreement Prospectus Covering Offering up to $250 Mln of Common Stock That May Be Issued From Time to Time

Reuters16:15 ET

Express News | Praxis Precision Medicines Inc Files for Mixed Shelf- SEC Filing

Reuters16:14 ET

Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Moomoo NewsDec 20 13:31 ET · Ratings

Praxis Precision Medicines (PRAX) Gets a Buy From Truist Financial

TipRanksDec 20 12:39 ET · Ratings

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome; Praxis Plans To Initiate An All-DEE Trial (EMERALD), Inclusive Of Dravet Syndrome, In 1H2025

BenzingaDec 18 08:14 ET

Express News | Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

ReutersDec 18 08:00 ET

9 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 16 12:35 ET

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate

Simply Wall StDec 13 06:50 ET

H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120

Moomoo NewsDec 12 06:31 ET · Ratings

Praxis Precision Med Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow JonesDec 12 06:28 ET · Ratings

Promising Pipeline and Strategic Developments Position Praxis Precision Medicines for Market Expansion

TipRanksDec 12 06:16 ET

Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $305

Moomoo NewsDec 11 14:31 ET · Ratings

Express News | Praxis Precision Medicines Inc : Jefferies Raises Target Price to $305 From $144

ReutersDec 11 07:47 ET

GeneDx Announces Biogen, Praxis Precision Medicines And Stoke Therapeutics As The Founding Partners To Its Patient Access Program For Pediatric Epilepsy, Which Provides Access To Whole Exome Sequencing.

BenzingaDec 5 08:54 ET

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients With New Partners

BusinesswireDec 5 08:30 ET

Praxis Precision Medicines to Present at Upcoming December Investor Conferences

GlobeNewswireDec 3 08:00 ET

Praxis Precision Medicines to Showcase Updates From Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

GlobeNewswireNov 26 08:00 ET

Praxis Solutions Welcomes Andre Hatibi as Senior Vice President of Business Development

PR NewswireNov 21 06:00 ET

Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270

Moomoo NewsNov 12 07:31 ET · Ratings

Piper Sandler Gives a Buy Rating to Praxis Precision Medicines (PRAX)

TipRanksNov 12 06:35 ET · Ratings